NewslettersCell Therapy News MAGE-A4 pMHC-Targeted CAR-T Cells Exploiting TCR Machinery Exhibit Significantly Improved In Vivo Function While Retaining Antigen Specificity By Jamie Kang - November 25, 2024 0 789 Researchers determined whether MAGE-A4 pMHC-targeted CAR-T cells using the T cell receptor machinery exhibited superior functionality without compromising antigen specificity. [Journal of Immunotherapy of Cancer] Full Article